Member Info for Amers

FB2020 and other no brainers.

All the people slagging DN over 180 for being friendly with BOD — have you never heard the saying “it’s good to keep your enemies closer”?

52UY too early to say, but it will fall big time.

Geraint12a IG showing opening price down 42% now, there could be blood bath, unless BOD comes up with something new.

Early indication opening price to be down around 25%.

Hi Muminr it was waste of time and now I am not going. 31st is my B/D and decided to stay at home, I have my bro and his family coming down from Liverpool.

Systemzero is the company’s largest shareholder and has been funding the business with his own capital.

Eureka01, no one is denying that further funds will need to be raised. However, with respect, it appears that the most recent RNS regarding DN’s loan has either not been reviewed or its significance has been overlooked.

A £1 million loan has been offered, and we also expect some funding from the government, as well as, hopefully, additional revenue from sales. With the £1 million loan in place, we would likely be looking to raise further funds around April or May.

It is difficult to predict what the share price will be at that time, but I am confident it would not be at 0.20p. One only has to consider the impact such a price would have had on your holding.

If you’d like it to sound more diplomatic or more firm, just let me know and I can refine it further.

Nissa don't worry, things will get better soon or later. Just one good RNS will take this to 2 to 5p in no time.

Hi JJ nice to see you posting....it's been long journey so far, hope this damn thing gets sorted for all human being.

Winni, I have many more ideas than you might realize. I spend a great deal of time reading and researching, and I also know people who work for the NHS. I am confident in my assessment. If the share price does not reach between 10p and 20p within the next 12 to 18 months, I will donate £1,000 to your chosen charity.

Hi Big where about do you live, as I may be going from hear Heathrow and would be happy to pick you up or anyone else.

Nissa they need to provide what their plans are for further funding/FDA/Sales and so on. 10 to 20p within next 12 months. One has to be mad, to sell it for 5p.

Junior and Big - There will be some news, before the AGM, as it is usual with most companies.

No msgs and only 21 trades

Light Reading

Below is the direction we intend to pursue, in coordination with the appropriate stakeholders. We may seek your support again as this progresses.

Review of Peel Hunt Relationship

We believe the relationship between Peel Hunt and the Board may be too close and potentially misaligned with shareholder interests. We will explore alternatives to replace Peel Hunt as broker.

No Immediate Need for a Capital Raise

Based on the latest RNS, the company has sufficient funds, and DN has committed to providing additional funding if and when required. Therefore, a near-term capital raise does not appear necessary.

FDA Application

An application to the FDA should be submitted as soon as possible. This must be treated as a priority.

Sales Team Assessment

We may need to evaluate the current sales team structure to determine whether changes—either additions or reductions—are needed to improve performance.

Board Composition Ahead of the AGM

Shareholders should express any views regarding the potential removal or replacement of Board members ahead of the upcoming AGM. It is important that we discuss these matters now rather than leaving them to the last minute.

Voting Access

Please ensure that your broker allows you to vote at the AGM and that you understand the process for submitting your vote.

Shareholder Representation on the Board

We should consider whether a shareholder representative should join the Board. This does not necessarily have to be DN; the priority is ensuring effective and accountable governance.

Additionally, we support postponing any capital raise until DN’s committed funds are fully utilised and operational efficiencies continue to extend the company’s runway. With the cash burn reduced from approximately £500k to around £350k, dilution should only occur if absolutely necessary and at a favourable valuation.

That should serve as a starting point for our discussions.

Stock and Other it says in the RNS, that further funding will be made avail, if needed. So I am sure we can be fully funded until well in to next year and application to the FDA can be made earlier.

Mist Thanks, so still live and kicking....good to hear that

I met David at the very first GM I attended and had a brief conversation with him. My initial impression was that he was a reserved, down-to-earth individual. At the time, some members of the Board and a few shareholders expressed doubts about trusting David. However, when I was urging everyone to vote against the 4 billion shares proposal, I had a feeling that David would ultimately support us, given the size of his holding in GDR.

All of you delivered a strong “No” vote, and for that I thank you. And now, I can also say a big thank-you to David for providing what was urgently needed.

My only regret is not having taken his contact number so I could personally thank him on behalf of all of us.

Let me remind everyone again: in my view, the share price has the potential to reach 10–20p within the next 12 to 18 months. Please don’t be tempted to sell at 2p, 4p, 6p, and so on. I’m confident that more information will come from the Board once the share price begins to move in the right direction.

Has anyone heard from Roger or seen him posting on any other BB's. Hope he is ok.

Hi Stephen11, could you please be kind enough to explain the RNS to Mr. Slacker, as he appears to be having some difficulty understanding it? Thanks.